Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
Innovations in Viral Clearance
Mock Viruses, Plant Design, and Rational Testing
For full access to this article login to GEN Select now.
Viral Clearance for Single Use and Steel
Don’t be satisfied with existing techniques for detecting and removing viral contaminants from recombinant bioproducts. Regulatory bodies aren’t.
- Viral clearance and quality control remain key challenges for biomanufacturers involved in both single-use and/or steel applications. New approaches and the latest thinking on ways to deal with viral clearance were topics of discussion at the recent Sartorius Stedim Biotech “European Upstream and Downstream Technology Forum,” which was held ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.